Efficacy of Energy Shots and Caffeine for Energy and Wakefulness Levels
NCT ID: NCT01755299
Last Updated: 2013-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2012-12-31
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Energy Drink on Repeated Sprint Performance and Cognitive Function in Athletes
NCT07104188
Exercise-Induced Rates of Fat Oxidation with and Without Ingestion of a Caffeine-Based Energy Drink
NCT06308731
Caffeine and Training Intensity Quantification
NCT06210984
Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health
NCT05170113
Pre-workout Supplement Versus Caffeine on Energy Expenditure.
NCT04539054
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active ingredient
Regular "5-hour Energy"
Regular "5-hour Energy"
Amount equivalent to the package commercially packaged and sold (1.93 fl. oz.)
Active ingredient-2
"5-hour Energy Decaf"
Decaf "5-hour Energy"
Commercially available "5-Hour Energy Decaf" product in the amount that is packaged (1.93 fl. oz.)
Active ingredient-3
Compounded caffeine product 135 mg/2 ounces
Compounded concentrated caffeine liquid
Concentrated caffeine liquid has been used to compound a 135 mg/2 ounce caffeine product, which contains the same amount of caffeine as a regular "5-hour Energy"
Placebo
Flavored placebo
Flavored bottled water
Bottled water will be flavored and colored to serve as a placebo product for this trial.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Regular "5-hour Energy"
Amount equivalent to the package commercially packaged and sold (1.93 fl. oz.)
Decaf "5-hour Energy"
Commercially available "5-Hour Energy Decaf" product in the amount that is packaged (1.93 fl. oz.)
Compounded concentrated caffeine liquid
Concentrated caffeine liquid has been used to compound a 135 mg/2 ounce caffeine product, which contains the same amount of caffeine as a regular "5-hour Energy"
Flavored bottled water
Bottled water will be flavored and colored to serve as a placebo product for this trial.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Subjects who are pregnant or breast-feeding
* Diagnosis of any of the following disease states:
* Attention Deficit Hyperactive Disorder
* Anxiety
* Coronary Artery Disease
* Cardiac arrhythmias
* Cerebral vascular accident
* Narcolepsy
* Seizure disorders
* Uncontrolled hypertension
* Active therapy with stimulant medications - any medications containing amphetamine, atomoxetine, dextroamphetamine, diethylpropion, lisdexamfetamine, methylphenidate, phentermine, or modafinil
* Use of decongestants or other products containing phenylephrine or pseudoephedrine for more than 15 days within the past 30 days
* Subjects who work third shift or rotate to two or more different shifts for their job, not allowing them to have a regular sleep schedule
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ProMedica Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michelle Piel
Pharmacy Resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Flower Hospital Family Medicine Residency
Sylvania, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Energy Shots Review
5-hour Energy Website
Source for caffeine content of many commercially available products
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5HE-TOL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.